{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:52:44Z","timestamp":1790275964508,"version":"4.1.0"},"reference-count":28,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T00:00:00Z","timestamp":1593302400000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Albireo AB"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,6,9]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>Untreated progressive familial intrahepatic cholestasis (PFIC) type 2, or bile salt exporter protein deficiency, frequently leads to severe pruritus, impaired growth and progressive liver fibrosis with risk of organ failure. We describe a 15-month-old male patient with severe pruritus diagnosed with PFIC type 2 enrolled in an open-label phase 2 study who received 4 weeks of treatment with odevixibat, an ileal bile acid transporter inhibitor under development for cholestatic liver disease treatment. The patient experienced reductions in serum bile acids and improvement in itching and sleep scores, and odevixibat was well tolerated. After the odevixibat study, symptoms returned and the patient underwent partial external biliary diversion (PEBD). Odevixibat treatment and PEBD produced similar normalisation of serum bile acid levels and improvements in pruritus and sleep disruptions. Thus, odevixibat appeared to be as effective as invasive PEBD in treating serum bile acids and cholestatic pruritus in this patient.<\/jats:p>","DOI":"10.1136\/bcr-2019-234185","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T02:15:20Z","timestamp":1593483320000},"page":"e234185","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Odevixibat and partial external biliary diversion showed equal improvement of cholestasis in a patient with progressive familial intrahepatic cholestasis"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct02630875","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03566238","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03659916","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03905330","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04185363","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04168385","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03566238","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03905330","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Christoph","family":"Slavetinsky","sequence":"first","affiliation":[{"name":"Paediatric Gastroenterology and Hepatology, University Children's Hospital, Eberhard Karls University Tubingen, Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Sturm","sequence":"additional","affiliation":[{"name":"Paediatric Gastroenterology and Hepatology, University Children's Hospital, Eberhard Karls University Tubingen, Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"2025082710480481000_13.6.e234185.1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.1999.01921.x"},{"key":"2025082710480481000_13.6.e234185.2","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S2210-7401(12)70018-9","article-title":"Progressive familial intrahepatic cholestasis","volume":"36 Suppl 1","author":"Jacquemin","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2025082710480481000_13.6.e234185.3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5500\/wjt.v6.i2.278","article-title":"Liver transplantation and the management of progressive familial intrahepatic cholestasis in children","volume":"6","author":"Mehl","year":"2016","journal-title":"World J Transplant"},{"key":"2025082710480481000_13.6.e234185.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2013.10.005"},{"key":"2025082710480481000_13.6.e234185.5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0016-5085(88)90301-0","article-title":"Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis","volume":"95","author":"Whitington","year":"1988","journal-title":"Gastroenterology"},{"key":"2025082710480481000_13.6.e234185.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"2025082710480481000_13.6.e234185.7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MPG.0b013e31819a4e3d","article-title":"Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease","volume":"49","author":"Yang","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025082710480481000_13.6.e234185.8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jpedsurg.2011.08.010","article-title":"Normalization of serum bile acids after partial external biliary diversion indicates an excellent long-term outcome in children with progressive familial intrahepatic cholestasis","volume":"47","author":"Schukfeh","year":"2012","journal-title":"J Pediatr Surg"},{"key":"2025082710480481000_13.6.e234185.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.11.012"},{"key":"2025082710480481000_13.6.e234185.10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jpedsurg.2007.03.029","article-title":"Partial internal biliary diversion through a cholecystojejunocolonic anastomosis--a novel surgical approach for patients with progressive familial intrahepatic cholestasis: a preliminary report","volume":"42","author":"Bustorff-Silva","year":"2007","journal-title":"J Pediatr Surg"},{"key":"2025082710480481000_13.6.e234185.11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3748\/wjg.v23.i5.763","article-title":"Current and future therapies for inherited cholestatic liver diseases","volume":"23","author":"van der Woerd","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2025082710480481000_13.6.e234185.12","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-018-0475-8"},{"key":"2025082710480481000_13.6.e234185.13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.02.007","article-title":"Genotype correlates with the natural history of severe bile salt export pump deficiency","author":"van Wessel","year":"2020","journal-title":"J Hepatol"},{"key":"2025082710480481000_13.6.e234185.14","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000002789","article-title":"Systematic review and meta-analysis: partial external biliary diversion in progressive familial intrahepatic cholestasis","author":"Verkade","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025082710480481000_13.6.e234185.15","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13457"},{"key":"2025082710480481000_13.6.e234185.16","first-page":"646A","article-title":"The ileal bile acid transport inhibitor A4250 reduced pruritus and serum bile acid levels in children with cholestatic liver disease and pruritus: final results from a multiple-dose, open-label, multinational study [abstract 1200]","volume":"66","author":"Sturm","year":"2017","journal-title":"Hepatology"},{"key":"2025082710480481000_13.6.e234185.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70287-8"},{"key":"2025082710480481000_13.6.e234185.18","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1246"},{"key":"2025082710480481000_13.6.e234185.19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1398-9995.2011.02577.x","article-title":"Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe","volume":"66","author":"Stalder","year":"2011","journal-title":"Allergy"},{"key":"2025082710480481000_13.6.e234185.20","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2015.04.003"},{"key":"2025082710480481000_13.6.e234185.21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306370200"},{"key":"2025082710480481000_13.6.e234185.22","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/hep.29019","article-title":"Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"2025082710480481000_13.6.e234185.23","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200868150-00006"},{"key":"2025082710480481000_13.6.e234185.24","doi-asserted-by":"crossref","DOI":"10.1097\/itx.0000000000000029","article-title":"Measurement tools for chronic pruritus: assessment of the symptom and the associated burden: a review","volume":"4","author":"Pereira","year":"2019","journal-title":"Itch"},{"key":"2025082710480481000_13.6.e234185.25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2340\/00015555-1620","article-title":"Pruritus assessment in clinical trials: consensus recommendations from the International forum for the study of itch (IFSI) special interest group scoring itch in clinical trials","volume":"93","author":"St\u00e4nder","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"2025082710480481000_13.6.e234185.26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40271-017-0266-4","article-title":"Development of a novel tool to assess the impact of Itching in pediatric cholestasis","volume":"11","author":"Kamath","year":"2018","journal-title":"Patient"},{"key":"2025082710480481000_13.6.e234185.27","unstructured":"Thompson R , Gwaltney C , Paty J , et al . Development of patient- and observer-reported outcome measures for paediatric cholestatic liver diseases [abstract]. Annual Meeting of the European Association for the Study of Liver Diseases; April 10-14, Vienna, Austria, 2019."},{"key":"2025082710480481000_13.6.e234185.28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21287"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-234185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:48:18Z","timestamp":1756316898000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-234185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,29]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/bcr-2019-234185"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-234185","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}